The recent proceedings at the World Health Assembly (WHA) have marked a pivotal shift in global health policy, with member states coalescing around a series of ambitious resolutions. From the drafting of a post-2030 roadmap to eradicate tuberculosis to groundbreaking initiatives addressing the silent epidemic of steatotic liver disease and the systemic neglect of rare bleeding disorders, the Assembly has set a new course for international health governance. Furthermore, in an era defined by rapid digital transformation, global leaders have elevated the fight against health-related misinformation to a top-tier security priority.
I. TB Eradication: A Post-2030 Vision
The Assembly’s decision to mandate a new post-2030 tuberculosis (TB) strategy reflects a sobering reality: while significant progress has been made, the current "End TB Strategy" is falling short of its 2030 Agenda targets.
The Mandate for 2028
The Director-General has been tasked with developing a robust, multi-stakeholder strategy to be presented at the Eighty-first World Health Assembly in 2028. This new framework will be calibrated to integrate with primary health care (PHC) systems and the broader universal health coverage (UHC) agenda. By aligning TB response with global health security, the strategy aims to move beyond vertical, disease-specific interventions toward a more holistic, resilient health infrastructure.
Supporting Data: Successes and Structural Barriers
Between 2000 and 2024, global health initiatives saved an estimated 83 million lives through expanded TB treatment. The year 2024 served as a landmark, witnessing the first post-pandemic decline in TB incidence and the highest levels of access to essential services in history. Despite these gains, the disease remains a leading infectious killer. The Assembly identified several structural bottlenecks preventing total eradication:
- Chronic Underfunding: Persistent gaps in research and implementation funding.
- Systemic Disruptions: The lingering impact of pandemic-related health system shocks.
- Social Determinants: Inequality, conflict, and climate-induced displacement continue to drive transmission in vulnerable populations.
II. Steatotic Liver Disease: Addressing a Growing NCD Challenge
In a landmark move, the Assembly formally recognized steatotic liver disease (SLD)—formerly known as fatty liver disease—as a major noncommunicable disease (NCD) threat.
The Scale of the Crisis
Affecting an estimated 1.7 billion people globally, SLD is rapidly becoming one of the most significant causes of chronic liver disease. The condition is intrinsically linked to the global rise in obesity, type 2 diabetes, and cardiovascular disease. If left unchecked, SLD creates a pipeline of patients requiring advanced care for fibrosis, cirrhosis, and liver cancer, placing an unsustainable burden on health systems worldwide.
Policy Implications: Integration and Multisectoral Action
The newly approved resolution mandates that Member States:
- Mainstream SLD into NCD Strategies: Move away from siloed treatments toward an integrated approach that addresses shared risk factors like unhealthy diets, physical inactivity, and alcohol consumption.
- Strengthen PHC Screening: Improve diagnostic capacity at the primary care level, specifically targeting children and adolescents.
- Surveillance and Awareness: Develop robust tracking mechanisms to monitor the prevalence of SLD and educate the public on early warning signs.
The WHO has committed to providing technical support and biennial progress reports, ensuring that SLD remains a permanent fixture on the international health agenda.
III. Equity for Rare Disorders: Haemophilia and Beyond
For decades, people living with haemophilia and other bleeding disorders have remained on the margins of global health policy. A new resolution adopted by the Assembly seeks to bridge this "equity gap," as it is estimated that 70% of those living with these conditions remain undiagnosed globally.
The Clinical Necessity
Haemophilia and related conditions—such as von Willebrand Disease—impair the blood’s ability to clot, leading to debilitating complications, internal damage, and, in severe cases, life-threatening hemorrhages. The lack of access to timely prophylaxis is a primary driver of disability in this patient population.
Commitments to Care
Member states have pledged to:
- Integrate Management: Incorporate bleeding disorder care into existing national policies for NCDs, UHC, and maternal health.
- Essential Medicines: Work toward the inclusion of life-saving therapies—including factor concentrates and novel non-factor treatments—in national Essential Medicines Lists.
- Combat Stigma: Launch public awareness campaigns to foster greater social integration for those living with these invisible disabilities.
IV. The Information Ecosystem: Combatting Health Disinformation
Perhaps the most forward-looking aspect of the Assembly was the Strategic Roundtable on health mis- and disinformation. Recognizing that a "resilient information ecosystem" is as vital to health outcomes as medicine itself, leaders from government, media, and technology sectors convened to address the erosion of public trust.
Disinformation as a Public Health Threat
The consensus among delegates was clear: disinformation is not merely a communication nuisance; it is a structural impediment to effective health interventions. The roundtable highlighted that when misinformation spreads, it undermines vaccination efforts, masks the severity of outbreaks, and alienates communities from legitimate healthcare providers.
Strategic Priorities
The Assembly identified a shift from reactive correction to proactive engagement. Key priorities moving forward include:
- Empowering Frontline Responders: Providing health workers and trusted community leaders with the tools and data necessary to debunk myths at the local level.
- Collaborating with Tech Platforms: Establishing formal channels with technology companies to ensure the prominence of evidence-based health information.
- Transparent Communication: Building trust through radical transparency regarding the limitations and advancements of scientific evidence.
V. Chronology of Developments and Future Outlook
- 2000–2024: Period of historic progress in TB reduction, with 83 million lives saved.
- 2024: Post-pandemic turning point for TB, marked by the highest-ever levels of service access.
- May 2026: Strategic roundtables held at the Seventy-ninth World Health Assembly to address digital misinformation.
- 2028: The Eighty-first World Health Assembly will receive the new, post-2030 TB strategy, coinciding with the UN High-Level Meeting on TB.
Implications for Global Health
The decisions made at this Assembly signal a move toward a more integrated and inclusive global health model. By addressing the "forgotten" diseases like haemophilia and emerging epidemics like SLD, the WHO is signaling that UHC cannot be achieved if specific demographics or conditions remain excluded from national policy frameworks.
The emphasis on information integrity also suggests that the WHO is evolving its role. It is no longer solely a technical body; it is increasingly becoming a strategic arbiter of the information landscape. As Member States return to their respective nations to implement these resolutions, the focus will now shift to funding and domestic policy translation. The path from the Assembly floor to the local clinic remains complex, but the institutional willpower displayed this week provides a robust foundation for the challenges of the next decade.
Official Responses and Strategic Significance
The resolutions passed during the session were not merely symbolic; they represent a coordinated effort to align global health goals with the practical realities of current epidemiological trends. By linking TB, NCDs, and rare diseases, the Assembly has created a cross-cutting framework that encourages countries to strengthen their primary health care infrastructure.
As the world prepares for the 2028 UN High-Level Meeting on TB, the pressure will be on Member States to demonstrate that they are not only meeting the diagnostic and treatment targets for infectious diseases but are also managing the growing, long-term burden of chronic conditions. The integration of these disparate health challenges into a single, cohesive agenda is the most significant development in international health policy in recent years. It suggests that the future of global health is not found in isolated vertical programs, but in the strength, resilience, and inclusivity of the health systems that serve the world’s most vulnerable populations.
About the Author
